Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
Clinical trial NCT02535689 · COMPLETED
Trial details
- NCT number
- NCT02535689
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-28
- Primary completion
- 2018-04-26
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.